financetom
Business
financetom
/
Business
/
S&P 500 Companies' Latest Quarterly Results More Positive Than Negative so Far, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
S&P 500 Companies' Latest Quarterly Results More Positive Than Negative so Far, Oppenheimer Says
Jul 29, 2024 11:12 AM

01:39 PM EDT, 07/29/2024 (MT Newswires) -- S&P 500 companies' quarterly financial results have been more positive than negative so far in the current reporting cycle, with four sectors seeing earnings grow by double-digit percentages on an annual basis, Oppenheimer Asset Management said Monday.

Some 206 or 41% of the companies in the benchmark equity index have reported their latest results so far, with earnings up 6.5% year over year on revenue growth of 4.1%, the firm said. Earnings are up at seven of the 11 S&P 500 sectors, led by technology's 19% jump and utilities' 18% gain. Financials and communication services have also posted double-digit earnings growth, while energy and real estate plunged by 17% and 15%, respectively, Oppenheimer said.

Sales are up from a year earlier for all 11 sectors, led by financials' 8.3% gain, followed by consumer discretionary, up 6.3%, according to the report.

Oppenheimer said 171 firms in the S&P 500 are scheduled to report results this week. These include mega-cap companies Apple ( AAPL ) , Microsoft ( MSFT ) , Facebook parent Meta Platforms ( META ) , and Amazon.com ( AMZN ) . Other big names include Intel ( INTC ) , Boeing ( BA ) , Pfizer ( PFE ) , AMD (AMD) and Exxon Mobil ( XOM ) . Some 78 firms will report next week, Oppenheimer said.

On Thursday, official data showed the US economy grew at a stronger-than-projected pace in the second quarter as consumer spending accelerated while inflation cooled. On Friday, government data showed the pace of US consumer spending growth eased in June, while the Federal Reserve's preferred inflation metric held steady on an annual basis.

"Last week's economic data suggested to us that the Fed has more reason to gain confidence in cutting interest rates without risk of an inflation blowback," Oppenheimer Asset Management Chief Investment Strategist John Stoltzfus said in a Monday note to clients. The data suggested the central bank's monetary policy committee could start lowering its benchmark lending rate as soon as in September, according to the note.

"In our view, if the Fed still isn't ready to cut (interest rates) as soon as September, then it's more likely in November and again in December at a pace of 25 basis points each," Stoltzfus said. "Overall, resilient growth and slowing inflation raise the odds of a 'soft landing' ahead."

Markets are widely expecting the Federal Open Market Committee to keep interest rates unchanged Wednesday and deliver a 25-basis-point cut in September, according to the CME FedWatch tool. The FOMC tightened monetary policy by 525 basis points from March 2022 through July 2023 to tame inflation, but has since kept interest rates unchanged, with its latest pause coming last month.

Price: 219.16, Change: +1.20, Percent Change: +0.55

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hims & Hers Health Approves $250 Million Share Buyback Plan
Hims & Hers Health Approves $250 Million Share Buyback Plan
Nov 17, 2025
10:09 AM EST, 11/17/2025 (MT Newswires) -- Hims & Hers Health ( HIMS ) said Monday its board approved a share buyback program of up to $250 million of its class A common shares over the next three years. The program follows the completion of a $100 million buyback plan set up in July 2024, which has now been fully...
LifeMD Offers Lower Cash-Pay Price for Novo Nordisk's Wegovy, Ozempic
LifeMD Offers Lower Cash-Pay Price for Novo Nordisk's Wegovy, Ozempic
Nov 17, 2025
10:08 AM EST, 11/17/2025 (MT Newswires) -- LifeMD ( LFMD ) said Monday it will offer the 0.25 milligram and 0.5 milligram doses of Novo Nordisk's ( NVO ) GLP-1 drugs Wegovy and Ozempic at a cash-pay price of $199 a month for two fills for new patients. Novo Nordisk ( NVO ) said earlier Monday that the medications are...
Ardurra Expands California Water Expertise with Acquisition of MKN & Associates
Ardurra Expands California Water Expertise with Acquisition of MKN & Associates
Nov 17, 2025
MIAMI--(BUSINESS WIRE)-- Ardurra Group, Inc. (Ardurra), a nationally recognized engineering and consulting firm, is pleased to announce the acquisition of MKN & Associates, Inc. (MKN), a respected California-based firm specializing in water and wastewater engineering services for municipalities and government agencies. Ardurra, ranked #75 on Engineering News-Record’s (ENR) Top 500 Design Firms list and consistently among the top 20 firms...
Brunswick Exploration Reports Strong Lithium Intercepts at Anatacau Main
Brunswick Exploration Reports Strong Lithium Intercepts at Anatacau Main
Nov 17, 2025
10:09 AM EST, 11/17/2025 (MT Newswires) -- Brunswick Exploration ( BRWXF ) said Monday that all drillholes from its Anatacau Main project, located in the Eeyou Istchee-James Bay region of Quebec, were centered on the Anais showing and intercepted multiple, large spodumene-bearing pegmatites with rich lithium mineralization. The company said highlights included 1.66% lithium oxide (Li2O) over 47.2 meters in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved